| __timestamp | Perrigo Company plc | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 152500000 | 15635076 |
| Thursday, January 1, 2015 | 187800000 | 23943601 |
| Friday, January 1, 2016 | 184000000 | 23689111 |
| Sunday, January 1, 2017 | 167700000 | 41006114 |
| Monday, January 1, 2018 | 218600000 | 51379106 |
| Tuesday, January 1, 2019 | 187400000 | 32705593 |
| Wednesday, January 1, 2020 | 177700000 | 53274000 |
| Friday, January 1, 2021 | 122000000 | 85352000 |
| Saturday, January 1, 2022 | 123100000 | 51999000 |
| Sunday, January 1, 2023 | 122500000 | 59471000 |
Unleashing the power of data
In the ever-evolving landscape of pharmaceuticals, innovation is the lifeblood of progress. Over the past decade, Summit Therapeutics Inc. and Perrigo Company plc have demonstrated contrasting approaches to research and development (R&D) spending. From 2014 to 2023, Perrigo's R&D expenses have seen a decline of approximately 20%, starting at 152 million in 2014 and dropping to 122 million by 2023. In contrast, Summit Therapeutics has increased its R&D investment by nearly 280%, from 15.6 million in 2014 to 59.5 million in 2023. This divergence highlights Summit's aggressive push towards innovation, while Perrigo appears to be optimizing its R&D budget. As the pharmaceutical industry continues to face challenges and opportunities, these spending patterns may significantly influence each company's future trajectory and market position.
Comparing Innovation Spending: Pfizer Inc. and Summit Therapeutics Inc.
Bristol-Myers Squibb Company vs Perrigo Company plc: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Biogen Inc. and Summit Therapeutics Inc.
Research and Development: Comparing Key Metrics for United Therapeutics Corporation and Summit Therapeutics Inc.
Genmab A/S or Perrigo Company plc: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Summit Therapeutics Inc. and Grifols, S.A.
Research and Development Investment: Summit Therapeutics Inc. vs Geron Corporation
Summit Therapeutics Inc. or Celldex Therapeutics, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Summit Therapeutics Inc. and Viridian Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Perrigo Company plc and Xenon Pharmaceuticals Inc.
R&D Spending Showdown: Perrigo Company plc vs Amicus Therapeutics, Inc.